We are a full-service early-phase contract research organisation (CRO) offering end-to-end drug development services from preclinical consultancy through to Phase III clinical trials. Our team brings together strategic insight and operational expertise to deliver a variety of clinical study types, including first-in-human and human challenge trials. To support rapid study start-up and reliable delivery, our dedicated recruitment teams in Germany and the UK provide direct access to both healthy volunteers and patient populations. This is complemented by our integrated infectious disease and immunology laboratories, which generate real-time data and insights to drive high-quality, adaptive trials.
We offer comprehensive preclinical consultancy and full clinical trial support. Our expertise includes a variety of study designs—including human challenge trials—and advanced laboratory methodologies to accelerate drug development.
hVIVO is currently recruiting participants to take part in our clinical trials to further medical research.
A global conference which facilitates learning and knowledge sharing on current research and development of vaccines, and to connect worldwide the leading researchers, scientists, physicians, industry, academic scientists, scholars, decision-makers, and representatives from regulatory, global health, and governmental organisations.
Bringing together the most senior and informed industry experts across the entire vaccine landscape and covering vaccine progress in: Infectious Diseases, Cancer Immunotherapy, One Health and Veterinary Vaccines, Clinical Development, Manufacture, Safety, Supply, Market Access & Emerging Infectious. From basic research to commercial manufacture, this meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress.
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
